Evidence of Increased Monocyte Inflammatory Activity in Acute Coronary Syndrome (ACS)
Kichi Tanoue, Hisao Ogawa(Kumamoto University Hospital), Yasushi Moriyama, Hironao Iwakiri, Eiichiro Yamamoto(Sapporo Medical University), Seiji Hokimoto(Kumamoto University), Katsuo Noda(Saiseikai Kumamoto Hospital), Taro Saito(Tokyo Metropolitan University), Shuuichi Ooshima
Japanese Circulation Journal-english Edition
March 31, 2002
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755